These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29154840)

  • 1. Thoughts on improving medication use.
    Novack GD
    Ocul Surf; 2018 Jan; 16(1):191-195. PubMed ID: 29154840
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmaceuticals and medical devices: cost savings.
    ; Steiner DJ
    Issue Brief Health Policy Track Serv; 2014 Dec; ():1-32. PubMed ID: 25771553
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmaceuticals and medical devices: Medicare Part D.
    ; Steiner DJ
    Issue Brief Health Policy Track Serv; 2014 Dec; ():1-31. PubMed ID: 25771554
    [No Abstract]   [Full Text] [Related]  

  • 4. New drugs for old: disinvestment and NICE.
    Hughes DA; Ferner RE
    BMJ; 2010 Feb; 340():c572. PubMed ID: 20185495
    [No Abstract]   [Full Text] [Related]  

  • 5. The Effect of Medicare Part D on Pharmaceutical Prices and Utilization.
    Duggan M; Morton FS
    Am Econ Rev; 2010 Mar; 100(1):590-607. PubMed ID: 29508975
    [No Abstract]   [Full Text] [Related]  

  • 6. [Medication supply of privately insured patients in 2010].
    Wild F
    Versicherungsmedizin; 2012 Jun; 64(2):85-6. PubMed ID: 22808648
    [No Abstract]   [Full Text] [Related]  

  • 7. [The new reference prices: an opportunity for efficient management of medication].
    Ausejo Segura M
    Aten Primaria; 2005 Feb; 35(2):64-6. PubMed ID: 15727746
    [No Abstract]   [Full Text] [Related]  

  • 8. Third-party reimbursement for generic prescription drugs: The prevalence of below-cost reimbursement in an environment of maximum allowable cost-based reimbursement.
    Murry L; Gerleman B; Urick B; Urmie J
    J Am Pharm Assoc (2003); 2018; 58(4):421-425. PubMed ID: 29861152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Encouraging generic use can yield significant savings.
    Zimmerman C
    Find Brief; 2012 Nov; 15(8):1-3. PubMed ID: 23213854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower your drug costs.
    Santa J
    Consum Rep; 2009 Jun; 74(6):13. PubMed ID: 19455768
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost variability of suggested generic treatment alternatives under the Medicare Part D benefit.
    Patel RA; Walberg MP; Tong E; Tan F; Rummel AE; Woelfel JA; Carr-Lopez SM; Galal SM
    J Manag Care Spec Pharm; 2014 Mar; 20(3):283-90. PubMed ID: 24564812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addressing Pharmaceutical Price Spikes Through Generic Preclearance.
    Sachs RE
    J Leg Med; 2019; 39(2):169-176. PubMed ID: 31503530
    [No Abstract]   [Full Text] [Related]  

  • 13. Web-based survey to assess the perceptions of managed care organization representatives on use of copay subsidy coupons for prescription drugs.
    Nemlekar P; Shepherd M; Lawson K; Rush S
    J Manag Care Pharm; 2013 Oct; 19(8):602-8. PubMed ID: 24074006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceuticals and Medical Devices: Cost Savings.
    Steiner DJ;
    Issue Brief Health Policy Track Serv; 2018 Dec; 2018():1-31. PubMed ID: 30695849
    [No Abstract]   [Full Text] [Related]  

  • 15. Prices of Generic Drugs Associated with Numbers of Manufacturers.
    Dave CV; Hartzema A; Kesselheim AS
    N Engl J Med; 2017 Dec; 377(26):2597-2598. PubMed ID: 29281576
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug coupons don't always save money.
    Consum Rep; 2009 Feb; 74(2):13. PubMed ID: 19306503
    [No Abstract]   [Full Text] [Related]  

  • 17. Association between US Pharmacopeia (USP) monograph standards, generic entry and prescription drug costs.
    Murimi-Worstell IB; Ballreich JM; Seamans MJ; Alexander GC
    PLoS One; 2019; 14(11):e0225109. PubMed ID: 31714946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VBID, the PPACA, and FREEE medications: Did politics trump the evidence about cost sharing?
    Fairman KA; Curtiss FR
    J Manag Care Pharm; 2012 Mar; 18(2):146-55. PubMed ID: 22380473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Big savings with new generic drugs.
    Consum Rep; 2014 May; 79(5):12. PubMed ID: 24724211
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.